Avadel Pharmaceuticals (AVDL)
(Delayed Data from NSDQ)
$11.10 USD
-0.05 (-0.45%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $11.12 +0.02 (0.18%) 7:22 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
AVDL 11.10 -0.05(-0.45%)
Will AVDL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AVDL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVDL
Wall Street Analysts See an 81.61% Upside in Avadel (AVDL): Can the Stock Really Move This High?
Surging Earnings Estimates Signal Upside for Avadel (AVDL) Stock
AVDL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Avadel (AVDL) Could Surge 97.68%: Read This Before Placing a Bet
All You Need to Know About Avadel (AVDL) Rating Upgrade to Buy
Earnings Estimates Moving Higher for Avadel (AVDL): Time to Buy?
Other News for AVDL
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial ...
Avadel Pharmaceuticals PLC (AVDL) Announces Upcoming Conference Call for Q2 2025 Financial ...
Avadel Pharmaceuticals PLC (AVDL) Shares Up 3.92% on Jul 21
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | AVDL Stock News
AVDL: HC Wainwright & Co. Announces Buy Rating with $22 Price Target | AVDL Stock News